MONTELUCAST APPLICATION IN TREATMENT FOR BRONCHIAL ASTHMA OF VARIOUS SEVERITY
Occurrence of bronchial asthma is growing. The experts have proved its genetic and clinical heterogeneity. This is what also calls forth incomplete response to the conventional anti inflammatory medications. During asthma, dozens of various mediators take an active part in the pathogenesis of inflam...
Saved in:
Main Authors: | A.V. Kamaev, D.S. Korostovtsev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2007-08-01
|
Series: | Педиатрическая фармакология |
Online Access: | https://www.pedpharma.ru/jour/article/view/703 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The feasibility of allergen-specific immunotherapy for bronchial asthma in children with polysensitization
by: O. V. Trusova, et al.
Published: (2024-06-01) -
Modern Understanding of Severe Bronchial Asthma
by: A. Yu. Kraposhina, et al.
Published: (2022-03-01) -
CLINICAL AND PATHOGENETIC EFFECTIVENESS OF VARIOUS PHARMACOTHERAPEUTIC MODES IN SEVERE BRONCHIAL ASTHMA IN CHILDREN
by: L.M. Ogorodova, et al.
Published: (2006-06-01) -
INCIDENCE OF BRONCHIAL ASTHMA SYMPTOMS IN CHILDREN IN DUSHANBE
by: D.S. Umarov, et al.
Published: (2008-03-01) -
SYSTEMIC ENZYME THERAPY IN COMPLEX TREATMENT OF PATIENTS WITH SEVERE BRONCHIAL ASTHMA
by: E. V. Churyukina, et al.
Published: (2019-05-01)